Company Filing History:
Years Active: 2000-2018
Title: Takayuki Matsuzaki: Innovator in Pharmaceutical Compounds
Introduction
Takayuki Matsuzaki is a prominent inventor based in Tokushima, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as monoamines reuptake inhibitors. With a total of 12 patents to his name, Matsuzaki's work has the potential to impact therapeutic practices significantly.
Latest Patents
Matsuzaki's latest patents include innovative N,N-substituted 3-aminopyrrolidine compounds. These compounds are useful as monoamines reuptake inhibitors. The present invention provides a pyrrolidine compound of General Formula (1) or a salt thereof, wherein R and R' are each independently a phenyl group or a pyridyl group. The phenyl group or the pyridyl group may have one or more substituents selected from halogen atoms and lower alkyl groups, which may also be optionally substituted with one or more halogen atoms. The pyrrolidine compound or a salt thereof is usable to produce a pharmaceutical preparation that has a wider therapeutic spectrum and can exhibit sufficient therapeutic effects after short-term administration.
Career Highlights
Matsuzaki is currently associated with Otsuka Pharmaceutical Company, Limited, where he continues to innovate and develop new pharmaceutical solutions. His work is characterized by a commitment to enhancing therapeutic options for various medical conditions.
Collaborations
Matsuzaki has collaborated with notable colleagues, including Muneaki Kurimura and Tomoichi Shinohara. These collaborations have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Takayuki Matsuzaki is a key figure in the pharmaceutical industry, with a focus on developing innovative compounds that can improve therapeutic outcomes. His contributions through his patents and collaborations highlight his dedication to advancing medical science.